An Efficacy and Safety Study of Golimumab in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy

NCT00264550 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

444

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Golimumab 100 mg
DRUG: Golimumab 50 mg
DRUG: Methotrexate
DRUG: Placebo injection
DRUG: Placebo capsules

Sponsor

Centocor, Inc.

Collaborators

[object Object]